Production (Stage)
Bright Minds Biosciences Inc.
DRUG
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 784.23% | 685.91% | -15.12% | -26.34% | -38.72% |
| Total Receivables | -60.23% | 36.66% | 36.26% | -83.91% | 1,554.25% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2,371.68% | 637.86% | 682.44% | -60.19% | -91.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 716.09% | 681.41% | -12.00% | -27.62% | -34.28% |
|
|
|||||
| Total Current Assets | 716.09% | 681.41% | -12.00% | -27.62% | -34.28% |
| Net Property, Plant & Equipment | 382.06% | 236.07% | 77.39% | -86.21% | -70.62% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 714.55% | 678.28% | -11.14% | -28.21% | -34.66% |
|
|
|||||
| Total Accounts Payable | -35.18% | -57.11% | 123.81% | -77.51% | 222.75% |
| Total Accrued Expenses | -14.86% | -- | 67.03% | -- | -98.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 111.33% | 22.28% | 8.09% | -82.53% | -52.94% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -28.95% | -50.40% | 88.49% | -76.02% | -15.98% |
|
|
|||||
| Total Current Liabilities | -28.95% | -50.40% | 88.49% | -76.02% | -15.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -19.04% | -38.57% | 102.60% | -76.48% | -18.78% |
|
|
|||||
| Common Stock & APIC | 141.65% | 133.13% | 4.59% | -0.02% | 3.25% |
| Retained Earnings | -3.81% | 5.27% | -9.03% | -8.21% | -18.27% |
| Treasury Stock & Other | -34.34% | -32.39% | 5.60% | 16.90% | 23.59% |
| Total Common Equity | 823.68% | 779.78% | -15.98% | -23.62% | -36.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 823.68% | 779.78% | -15.98% | -23.62% | -36.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 823.68% | 779.78% | -15.98% | -23.62% | -36.50% |
|
|
|||||